A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa
Trial details
- Registry ID
- NCT06603077
- Drugs studied
- AVTX-009 Regimen 1, AVTX-009 Regimen 2
TrialRedline tracks 2 clinical trials sponsored by Avalo Therapeutics, Inc.: 2 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaNCT06603077 | AVTX-009 Regimen 1, AVTX-009 Regimen 2 | Completed | 2026-02-23Actual |
| A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.NCT05288504 | AVTX-002 | Completed | 2023-05-11Actual |
Names as written in the registry records.
NCT06603077 · Avalo Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 250 participants (planned). After: 253 participants (actual).
Before: Active not recruiting. After: Completed.
NCT06603077 · Avalo Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: Mar 2026. After: 23 Feb 2026.